Clinical Trial Update: Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates unrelated cord blood transplantation for Epstein-Barr virus–associated lymphoproliferative diseases, chronic active EBV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Epstein-barr Virus Infection
• Epstein-barr Virus Associated Lymphoma
• Epstein-barr Virus-associated Lymphoproliferative Disease

Snippet

Sponsor: Fudan University | Conditions: Epstein-Barr Virus-associated Lymphoproliferative Diseases, Chronic Active Epstein-Barr Virus Infection | Phase 2 | Status: RECRUITING